Grant of Lipid Nutrient Supplement Prenatal in Stunting Prevention: A Systematic Review

Introduction: This article examining the effectiveness of the administration of Lipid-based Nutrient Supplement (LNS) during prenatal in preventing stunting. One of the risk factors for stunting is the lack of nutritional intake during pregnancy, so an effective intervention is needed to prevent stunting from the time the fetus is in the womb. This study aims to find out the effectiveness of giving LNS during the prenatal period in preventing stunting. Methods: Databases used are PubMed, EBSCOhost, Cochrane Library, and Oxford Academic. It's sorted using the keywords pregnant women AND lipid nutrient supplement OR lipid-based nutrient AND prevent stunting. The inclusion criteria for articles in English or Indonesian, year published in 2011-2021, RCT research methods, availability of full text on articles, the suitability of the title, the population in the study is pregnant women, and the focus of research is on the use of Lipid Nutrient Supplement (LNS) or Lipid Based Nutrient (LBN) against stunting. The feasibility assessment using Jadad Score. Results: The analysis of 9 selected articles showed LNS affected prevention of growth retardation measured from age length Z value (LAZ), age weight Z value (WAZ) and Z-measurement. Circumference height (HCZ) score, no display value <2.0 indicates that the incidence of developmental delay and body mass index (BMIZ) Z score, upper-middle arm circumference (MUAC), and body length aren't lower than the average. Conclusion: The results of the study showed that LNS prenatal administration has a high effectiveness in preventing stunting.